ReviewTrends in pharmacological sciences2011

Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.

Christopher H Switzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.